1.445RON0.00%Mkt Cap: 1.42B RONP/E: 16.00Last update: 2026-05-28
Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermato…
Industry Peers
Drug Manufacturers - Specialty & Generic153.56BSEKP/E 168.1
60.92BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.48BUSDP/E 20.5
18.75BUSD—
15.99BUSDP/E 24.5
13.18BSEKP/E 39.7
Indicators:|
Key Statistics
Company
Market Cap1.42B RON
Enterprise Value1.19B RON
Revenue (TTM)316.75M RON
Gross Profit272.89M RON
Net Income (TTM)100.63M RON
Revenue/Share0.3210 RON
Last Price1.445 RON
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees374
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROBIOFACNOR9
Valuation
P/E (Trailing)16.00
P/E (Forward)—
PEG—
EV/EBITDA10.33
EV/Revenue3.75
P/S4.48
P/B2.44
EPS (TTM)0.09
EPS (Forward)—
52W Range
0.702096% of range1.475
52W High1.475 RON
52W Low0.7020 RON
Profitability
Gross Margin85.46%
Oper. Margin38.40%
EBITDA Margin36.32%
Profit Margin31.51%
ROE18.35%
ROA15.80%
Growth
Revenue Growth-2.70%
Earnings Growth0.60%
Cash Flow & Leverage
Operating CF80.52M RON
CapEx (TTM)14.67M RON
FCF Margin18.33%
FCF Yield4.09%
Net Debt-230.37M RON
Net Debt/EBITDA-2.00
Balance Sheet
Debt/Equity0.00
Current Ratio4.93
Quick Ratio4.22
Book Value/Sh0.5900 RON
Cash/Share0.2350 RON
Dividends
Fwd Div Rate0.0400 RON
Trail. Div Rate0.0420 RON
Div. Yield2.91%
5Y Avg Yield3.65%
Payout Ratio33.59%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.985.37M
Float476.14M
Insiders0.00%
Institutions88.43%
Technical
SMA 501.317 (+9.8%)
SMA 2001.026 (+40.9%)
Beta0.44
S&P 52W Chg27.94%
Avg Vol (30d)178.56K
Avg Vol (10d)151.78K
Technical Indicators
RSI (14)65.8
MACD0.0417
MACD Signal0.0436
MACD Hist.-0.0020
BB Upper1.573 RON
BB Middle1.398 RON
BB Lower1.224 RON
BB Width24.94%
ATR (14)0.0316 RON
Vol Ratio (20d)0.37x